About Accugenix
Accugenix is a company based in Newark (United States) founded in 1990 was acquired by Charles River Laboratories in August 2012. Accugenix offers products and services including Research Models and Services, Antibody Discovery Services, Integrated Drug Discovery, and Biologics Testing Solutions. Accugenix operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, AFYREN and Nordic Bioscience, among others.
- Headquarter Newark, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Charles River Laboratories
(Aug 29, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accugenix
Accugenix offers a comprehensive portfolio of products and services, including Research Models and Services, Antibody Discovery Services, Integrated Drug Discovery, and Biologics Testing Solutions.
Provides animal models and support for basic research in pharmaceuticals.
Offers comprehensive antibody development for therapeutic applications.
Manages target discovery to lead optimization for faster drug pipelines.
Conducts global testing for biologics from discovery to commercialization.
Funding Insights of Accugenix
Detailed funding history for Accugenix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Accugenix
Accugenix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug discovery and preclinical development services
|
Locked | Locked | Locked |
Investor details for Accugenix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accugenix
Investment portfolio details for Accugenix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accugenix
Detailed financials for Accugenix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accugenix Comparisons
Peer comparison for Accugenix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accugenix
Accugenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, AFYREN and Nordic Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Integrated R&D services are provided for pharmaceuticals and allied sectors.
|
Detailed competitors of Accugenix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accugenix
Complete news archive for Accugenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accugenix
Accugenix was founded in 1990.
Accugenix is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
Accugenix was founded in 1990 in Newark, United States, and acquired by Charles River Labs in 2012. Services in the microbiological testing sector focus on bacterial and fungal identification, strain typing, and environmental isolate analysis. DNA sequencing and MALDI-TOF technologies are employed, supported by proprietary libraries developed over two decades. Operations extend to more than 1,000 facilities worldwide, including genotypic identification, microbial detection, proteotypic analysis, and sequence-based methods.
Accugenix's top competitors include Alderley Analytical, BioAgilytix and AFYREN.
Accugenix offers Research Models and Services, Antibody Discovery Services, Integrated Drug Discovery, and Biologics Testing Solutions.
Accugenix has 1 investor. Key investors include Charles River Laboratories.